Supernus Pharmaceuticals | Umsatzkosten



Cost Of Sales Veränderung Datum
Abbott USD 4.94B 246M 2024-12
ANI Pharmaceuticals USD 80.28M 68.05M 2024-12
Aurora Cannabis CAD 78.85M 891K 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.96M 89K 2024-12
Eisai JPY 45.94B 3.42B 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Indivior 59M 7M 2024-09
Novo Nordisk 11.31B 1.03B 2024-09
Pacira USD 39.89M 1.02M 2024-12
Perrigo USD 752.4M 69.3M 2024-12
Pfizer USD 5.65B 781M 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
United Therapeutics USD 75.9M 7.2M 2024-12
Xeris Pharmaceuticals USD 9.48M 4.12M 2024-12



Supernus Pharmaceuticals Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.